Announcements Trials
Browse Landscape

Phase

Phase NA 25Phase EARLY_PHASE1 3Phase 2 3Phase 4 1Phase 3 1Phase 1/2 1Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 9Gastrointestinal 4Tumor-Agnostic 3Other hematologic neoplasm 3Genitourinary 2CNS 2Thoracic 1Other 1Gynecologic 1

Conditions

Motor Activity 3Leukemia, Myeloid, Acute 3Fatigue 1

Interventions

Cyclophosphamide 413Cytarabine 336fludarabine phosphate 231Rituximab 206Methotrexate 198fludarabine 195venetoclax 174Azacitidine 174Busulfan 169Filgrastim 145Whole-Body Irradiation 143Mycophenolic Acid 143Peripheral Blood Stem Cell Transplantation 141Tacrolimus 138Etoposide 130Vincristine 112Melphalan 110Dexamethasone 109Cyclosporine 102Granulocyte Colony-Stimulating Factor 100Imatinib Mesylate 94Antilymphocyte Serum 91Daunorubicin 90Radiotherapy 84Decitabine 83Dasatinib 76Lenalidomide 75Doxorubicin 70Prednisone 68Idarubicin 68

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Exercise × Other hematologic neoplasm × Clear all
NCT01446081 2019-11-25

An Exercise Trial for Acute Myeloid Leukaemia (AML) Patients Undergoing Induction Chemotherapy

University Health Network, Toronto

Phase 2 Completed
83 enrolled
Other hematologic neoplasm

Motor Activity, Leukemia, Myeloid, Acute

NCT01170598 2012-04-20

Acute Myeloid Leukaemia (AML) Patients Undergoing Induction Chemotherapy

Toronto Rehabilitation Institute

Phase 2 Completed
35 enrolled 15 charts
Other hematologic neoplasm

Motor Activity, Leukemia, Myeloid, Acute

NCT00764231 2012-02-08

A Study of a Home-based Exercise Intervention for Patients With Acute Myeloid Leukaemia (AML)

Toronto Rehabilitation Institute

Phase 2 Completed
40 enrolled
Other hematologic neoplasm

Fatigue, Motor Activity, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡